Marpai Adds 19,000 Covered Lives Through Two Major Client Contracts

BenzingaBenzinga
|||1 min read
Key Takeaway

Marpai gains 19,000 covered lives through two major enterprise contracts for its pharmacy benefit management platform, with full operations expected in Q2 2026.

Marpai Adds 19,000 Covered Lives Through Two Major Client Contracts

Marpai, Inc. announced the addition of two significant enterprise clients to its MarpaiRx pharmacy benefit management platform, collectively representing over 19,000 covered lives. The first contract encompasses rebate management services for approximately 16,000 employees through a strategic collaboration, while the second agreement adds more than 3,000 employees requiring both third-party administrator (TPA) and rebate management services. Both implementations are scheduled to reach full operational status in early Q2 2026.

The company views these client acquisitions as validation of its technology-enabled PBM platform's competitive positioning in the market. Marpai has emphasized that these wins demonstrate demand for its integrated service offerings and represent a meaningful inflection point in the company's expansion trajectory. The contracts are expected to contribute meaningfully to the company's covered life base and recurring revenue streams as implementations progress through 2025 and into 2026.

Source: Benzinga

Back to newsPublished Feb 23

Related Coverage

Benzinga

Banzai to Acquire ConnectAndSell Assets, Doubling Revenue With AI-Powered Sales Platform

Banzai to acquire ConnectAndSell's profitable AI sales platform, adding $15M annual revenue and doubling overall scale by early Q2 2026.

BNZIBNZIW
Benzinga

TEN Holdings Loses $19.5M in Maiden Year as Public Company Despite Revenue Decline

TEN Holdings reported $3.1M revenues (down 11.4%) and $19.5M net loss in its first year as public company, offset by doubled customer acquisitions and strategic partnerships.

XHLD
GlobeNewswire Inc.

Surgical Stapling Devices Market to Nearly Double to $10.1B by 2035

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.

JNJMDTISRG
The Motley Fool

Three Under-the-Radar AI Stocks Poised for Explosive Growth in Niche Markets

Three smaller AI companies—Weave, Evolv, and Pagaya—demonstrate strong revenue growth solving specific problems in healthcare, security, and lending, offering growth investors AI exposure beyond mega-cap leaders.

PGYPGYWWWEAV
GlobeNewswire Inc.

Aclarion CEO to Showcase NOCISCAN Platform at LSI USA 2026 Conference

Aclarion CEO to present NOCISCAN platform at LSI USA 2026 investor conference, advancing AI-powered diagnostic technology for chronic low back pain identification.

ACONACONW
GlobeNewswire Inc.

Philips Scales Digital Pathology With AWS Cloud Platform

Philips launches cloud-based digital pathology platform powered by AWS, enabling healthcare organizations to scale diagnostic workflows without on-premise infrastructure.

PHG